Download FREE Report Sample
Download Free sampleGeneric and Biosimilar Pharmaceuticals Market contains market size and forecasts of Generic and Biosimilar Pharmaceuticals in Global, including the following market information:
Global Generic and Biosimilar Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Generic and Biosimilar Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Generic and Biosimilar Pharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Generic and Biosimilar Pharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic and Biosimilar Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Generic and Biosimilar Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Global Generic and Biosimilar Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Generic and Biosimilar Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Global Generic and Biosimilar Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Generic and Biosimilar Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Generic and Biosimilar Pharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Generic and Biosimilar Pharmaceuticals revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
